Thus, as in AIA, GM-CSFRα in AIP can be detected on certain myeloid populations and anti-GM-CSFRα administration led to a preferential reduction of Mo-DCs, indicating again the convenience of the AIP model in understanding the role of GM-CSF in inflammation. The gene discussed is CSF2; the disease is autoimmune pancreatitis.